未登录

P

Philipp Treskes

University of Edinburgh

H指数:10

被引数:329

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oxygen Plasma Substrate and Specific Nanopattern Promote Early Differentiation of HepaRG Progenitors

TISSUE ENGINEERING PART A

IF2.9

2020-10-012

OAAI

Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-03-0128

OAAI

Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport

基于HepaRG祖细胞的生物人工肝的放大: 临床应用和运输的优化

IF8

2017-06-3010

PREAI

Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver

SCIENTIFIC REPORTS

IF3.9

2017-01-3033

OAAI

Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? (vol 14, 86, 2015)

LIPIDS IN HEALTH AND DISEASE

IF4.2

2016-08-010

OAAI

ESTABLISHING THE EDINBURGH MODEL: DOSE TO INJURY RESPONSE IN A LARGE ANIMAL INFUSION MODEL OF PARACETAMOL-INDUCED ACUTE LIVER FAILURE

JOURNAL OF HEPATOLOGY

IF33

2016-01-010

PREAI

EFFECTS OF HEALTHY- AND ACUTE LIVER FAILURE PLASMA ON DIFFERENTIATED HUMAN HEPARG PROGENITOR CELLS IN MONOLAYERS AND BIOARTIFICIAL LIVERS

JOURNAL OF HEPATOLOGY

IF33

2016-01-010

PREAI

Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture model

SCIENTIFIC REPORTS

IF3.9

2015-12-0342

OAAI

MECHANISTIC INSIGHT INTO ACETAMINOPHEN-INDUCED HEPATIC TIGHT JUNCTION DISRUPTION USING A HUMAN HepaRG-BASED LIVERBIOCHIP IMPEDANCE BIOSENSOR

JOURNAL OF HEPATOLOGY

IF33

2015-04-010

PREAI

INVESTIGATING PARACETAMOL TOXICITY IN HepaRG-BASED 3D HUMAN HEPATIC ORGANOTYPIC MODELS WITH NON-INVASIVE OPTICAL COHERENCE PHASE MICROSCOPY (OCPM)

JOURNAL OF HEPATOLOGY

IF33

2015-04-010

PREAI

Dynamic Support Culture of Murine Skeletal Muscle-Derived Stem Cells Improves Their Cardiogenic Potential In Vitro

STEM CELLS INTERNATIONAL

IF3.3

2015-01-013

OAAI

HUMAN HEPATIC HepaRG CELLS MAINTAIN HIGH INTRINSIC CYP450 ACTIVITY/METABOLISM AND SIGNIFICANTLY OUTPERFORM STANDARD HepG2/C3A CELLS USED IN DRUG PHARMACOLOGY APPLICATIONS

JOURNAL OF HEPATOLOGY

IF33

2014-04-010

OAAI

DEVELOPMENT OF HUMAN HEPATIC HepaRG CELL-BASED LiverBioChip PROTOTYPES USING ELECTRON BEAM LITHOGRAPHY DIRECTED-NANOPATTERNING FOR HTS-COMPATIBLE PRE-CLINICAL DRUG EVALUATION APPLICATIONS

JOURNAL OF HEPATOLOGY

IF33

2014-04-010

PREAI

HUMAN HEPATIC HepaRG CO-CULTURE MODEL AS A SENSITIVE AND NON-INVASIVE TOXICOLOGICAL PLATFORM USING ECIS (ELECTRICAL CELL-SUBSTRATE IMPEDANCE SENSING) BIOSENSORS

JOURNAL OF HEPATOLOGY

IF33

2014-04-010

PREAI

Noninvasive In Vivo Tracking of Mesenchymal Stem Cells and Evaluation of Cell Therapeutic Effects in a Murine Model Using a Clinical 3.0 T MRI

CELL TRANSPLANTATION

IF3.2

2013-11-0120

OAAI

Profiling the Impact of Medium Formulation on Morphology and Functionality of Primary Hepatocytes in vitro

SCIENTIFIC REPORTS

IF3.9

2013-09-2422

OAAI